Lipid-Modifying Agents to Treat or Prevent COVID-19?

Work exploring the potential use of lipid-modulating agents for the prevention and treatment of COVID-19 infection is ongoing. A new analysis has identified and reviewed 40 randomized clinical trials (RCTs) investigating the potential use of such agent, including statins, omega-3 fatty acids, fibrates, niacin, and dalcetrapib, to prevent or treat COVID-19. […]